Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Statistics

Total Valuation

OBIO has a market cap or net worth of $204.89 million. The enterprise value is $135.62 million.

Market Cap	204.89M
Enterprise Value	135.62M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

OBIO has 38.01 million shares outstanding. The number of shares has increased by 22.34% in one year.

Current Share Class	38.01M
Shares Outstanding	38.01M
Shares Change (YoY)	+22.34%
Shares Change (QoQ)	+5.09%
Owned by Insiders (%)	3.17%
Owned by Institutions (%)	21.38%
Float	18.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	71.99
Forward PS	53.65
PB Ratio	4.33
P/TBV Ratio	4.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	51.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.23, with a Debt / Equity ratio of 0.04.

Current Ratio	4.23
Quick Ratio	4.13
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.66% and return on invested capital (ROIC) is -53.98%.

Return on Equity (ROE)	-91.66%
Return on Assets (ROA)	-39.20%
Return on Capital (ROIC)	-53.98%
Revenue Per Employee	$47,268
Profits Per Employee	-$1.03M
Employee Count	56
Asset Turnover	0.03
Inventory Turnover	1.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.24% in the last 52 weeks. The beta is 0.41, so OBIO's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-22.24%
50-Day Moving Average	5.41
200-Day Moving Average	6.03
Relative Strength Index (RSI)	43.96
Average Volume (20 Days)	61,740

Short Selling Information

The latest short interest is 778,621, so 2.05% of the outstanding shares have been sold short.

Short Interest	778,621
Short Previous Month	826,071
Short % of Shares Out	2.05%
Short % of Float	4.29%
Short Ratio (days to cover)	17.03

Income Statement

In the last 12 months, OBIO had revenue of $2.65 million and -$57.69 million in losses. Loss per share was -$1.60.

Revenue	2.65M
Gross Profit	2.45M
Operating Income	-60.11M
Pretax Income	-51.64M
Net Income	-57.69M
EBITDA	-59.81M
EBIT	-60.11M
Loss Per Share	-$1.60

Balance Sheet

The company has $66.93 million in cash and $1.84 million in debt, giving a net cash position of $65.09 million or $1.71 per share.

Cash & Cash Equivalents	66.93M
Total Debt	1.84M
Net Cash	65.09M
Net Cash Per Share	$1.71
Equity (Book Value)	46.22M
Book Value Per Share	1.22
Working Capital	52.34M

Cash Flow

In the last 12 months, operating cash flow was -$47.99 million and capital expenditures -$180,000, giving a free cash flow of -$48.17 million.

Operating Cash Flow	-47.99M
Capital Expenditures	-180,000
Free Cash Flow	-48.17M
FCF Per Share	-$1.27

Margins

Gross Margin	92.71%
Operating Margin	-2,270.68%
Pretax Margin	-2,179.34%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,026.67%

Dividends & Yields

OBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.34%
Shareholder Yield	-22.34%
Earnings Yield	-28.74%
FCF Yield	-24.00%

Analyst Forecast

The average price target for OBIO is $15.75, which is 192.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.75
Price Target Difference	192.21%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	63.03%
EPS Growth Forecast (5Y)	-18.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OBIO has an Altman Z-Score of -2.41 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.41
Piotroski F-Score	1